Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ketoprofen Oral Gel vs OKi Granules
NCT04678076Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Jul 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Ketofen in pain (2 arms), sponsored by Angelini Pharma. Primary endpoints: Maximum plasma concentration of ketoprofen and Area under the concentration-time curve 0-t. Started Jul 2018; status: completed.
02
Drugs
Ketofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT04678076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678076.